HomeRPTX • NASDAQ
add
Repare Therapeutics Inc
Previous close
$1.33
Day range
$1.31 - $1.35
Year range
$0.89 - $4.29
Market cap
57.47M USD
Avg Volume
423.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.92M | 224.00% |
Net income | -30.04M | -328.26% |
Net profit margin | — | — |
Earnings per share | -0.63 | -310.00% |
EBITDA | -26.74M | -336.25% |
Effective tax rate | -1.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.23M | -47.58% |
Total assets | 144.02M | -45.26% |
Total liabilities | 18.93M | -39.21% |
Total equity | 125.10M | — |
Shares outstanding | 42.89M | — |
Price to book | 0.46 | — |
Return on assets | -43.56% | — |
Return on capital | -49.94% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.04M | -328.26% |
Cash from operations | -29.13M | -344.16% |
Cash from investing | 28.79M | 241.72% |
Cash from financing | 79.00K | -78.93% |
Net change in cash | -262.00K | 96.75% |
Free cash flow | -19.91M | -355.23% |
About
Founded
2016
Website
Employees
129
